You are here

  • Home
  • Archive
  • Volume 71, Issue 5
  • One-year outcomes of rosuvastatin versus placebo in sepsis-associated acute respiratory distress syndrome: prospective follow-up of SAILS randomised trial

Citation Tools

Article menu
Download PDFPDF
Critical care
Original article
One-year outcomes of rosuvastatin versus placebo in sepsis-associated acute respiratory distress syndrome: prospective follow-up of SAILS randomised trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Dinglas VD, Hopkins RO, Wozniak AW, et al
One-year outcomes of rosuvastatin versus placebo in sepsis-associated acute respiratory distress syndrome: prospective follow-up of SAILS randomised trial
Thorax 2016;71:401-410.